Across thousands of healthcare samples every month, labs face delays and inconsistencies. Much of this comes from imported tools that aren’t designed for Indian labs. By building in-house, we can take control and design solutions that actually fit local needs.

India is diverse. Samples, workflows, and lab conditions vary from city to city, hospital to hospital. One-size-fits-all solutions often fail.

By building locally, we adapt to these realities. Our reagents are designed for Indian samples. Our automation devices, DNA/RNA extraction systems, and NGS library prep tools fit lab spaces and workflows. Our software integrates seamlessly with lab processes.

Labs spend less time troubleshooting and more time producing reliable results. Research moves faster. Outcomes improve.

Supporting labs is a big part of this. On-ground teams are available quickly if issues arise. Need customization? We can do that too. Modules, protocols, and software can be adjusted to match unique lab requirements. Flexibility is built into every product.

Strengthening Make in India

Our in-house approach strengthens India’s self-reliance in biotech. Every device, every reagent, every workflow contributes to a stronger scientific ecosystem.

We are not just delivering products. We are building capability. We are creating jobs, developing local expertise, and nurturing homegrown innovation. That is what Make in India is about: creating solutions locally, for global standards.

As a part of this agenda, we are proud to announce that we are now officially DSIR-registered. The Department of Scientific & Industrial Research has recognised R&D capabilities. Our labs, our processes, our teams are all evaluated and validated.

View the certificate here.

DSIR registration is a big milestone for us, but the work continues. We will keep designing for labs, building in India, and driving genomics innovation that makes research easier, faster, and more reliable.